Quantcast

Latest Coumadin Stories

2008-07-07 18:00:31

Research and Markets (http://www.researchandmarkets.com/research/490602/cardiology_acute) has announced the addition of the "Cardiology - Acute Coronary Syndrome, Anticoagulants" report to their offering. This report provides in-depth analysis of the market and pipeline from the perspective of global thought leaders. This report is based on a series of seven full interviews with US Thought Leaders (emergency medicine, orthopedic surgery, interventional cardiology,...

2008-05-26 18:00:28

The U.S. Department of Health and Human Services has a guide to using the medication Coumadin, which is used to prevent blood clots. The HHS' Healthcare Research and Quality urges patients to read their 20-page brochure about the blood thinning drug entitled Your Guide to Coumadin/ Warfarin Therapy. The brochure alerts patients to what to watch for to avoid complications. Coumadin, usually monitored using periodic blood tests, is the second most common cause -- after insulin -- of...

2007-08-28 12:16:38

LOUISVILLE, Ky., Aug. 28 /PRNewswire/ -- In a milestone decision on August 17, 2007, the FDA announced important changes in the warfarin label (also known as Coumadin), recommending that a lower initial Coumadin dose "should be considered for patients with certain genetic variations." Coumadin is a commonly prescribed blood thinner with an extremely narrow safe-dosage range varying dramatically from patient to patient. Patients who take a dose larger than they can tolerate are at risk of...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.